Background. Age-related macular degeneration (AMD) is a leading cause of visual impairment and blindness. It is likely that treatment of AMD at earlier stages is more effec-tive than later treatment; thus, screening for AMD should be considered. The aim of this study was to develop a natural history model of AMD to estimate the cost-effectiveness of screening. Methods. A hybrid cohort/individual sampling decision analytic model was developed. Primary data sets, expert elicitation, and data from the literature were used to populate the model. To incorporate joint parameter uncertainty, and to populate unobservable parameters, an innovative form of probabilistic calibration was applied to a range of output parameters. Results. In the referenc...
PURPOSE: To present a computerized model assessing individualized cost utility for current treatment...
Abstract: Purpose. To study the population-based annual incidence rates of exudative, dry and all ca...
Age-related macular degeneration (AMD) is a disease that causes reduced visual acuity and blindness....
Background. Age-related macular degeneration (AMD) is a leading cause of visual impairment and blind...
Background. Age-related macular degeneration (AMD) is a leading cause of visual impairment and blind...
ObjectivesTo estimate the cost-effectiveness of screening for age-related macular degeneration (AMD)...
To investigate the cost-effectiveness of screening and subsequent intervention for age-related macul...
To investigate the cost-effectiveness of screening and subsequent intervention for age-related macul...
[Purpose] To investigate the effectiveness of screening and subsequent intervention for age-related ...
Purpose Prediction models for age-related macular degeneration (AMD) based on case-control studies h...
BackgroundInterventions that can facilitate early diagnosis of age-related macular degeneration (AMD...
Purpose: Prediction models for age-related macular degeneration (AMD) based on case-control studies ...
BACKGROUND:Interventions that can facilitate early diagnosis of age-related macular degeneration (AM...
Prediction models for age-related macular degeneration (AMD) based on case-control studies have a te...
Population-based studies across developed countries have estimated the prevalence rate of late age-r...
PURPOSE: To present a computerized model assessing individualized cost utility for current treatment...
Abstract: Purpose. To study the population-based annual incidence rates of exudative, dry and all ca...
Age-related macular degeneration (AMD) is a disease that causes reduced visual acuity and blindness....
Background. Age-related macular degeneration (AMD) is a leading cause of visual impairment and blind...
Background. Age-related macular degeneration (AMD) is a leading cause of visual impairment and blind...
ObjectivesTo estimate the cost-effectiveness of screening for age-related macular degeneration (AMD)...
To investigate the cost-effectiveness of screening and subsequent intervention for age-related macul...
To investigate the cost-effectiveness of screening and subsequent intervention for age-related macul...
[Purpose] To investigate the effectiveness of screening and subsequent intervention for age-related ...
Purpose Prediction models for age-related macular degeneration (AMD) based on case-control studies h...
BackgroundInterventions that can facilitate early diagnosis of age-related macular degeneration (AMD...
Purpose: Prediction models for age-related macular degeneration (AMD) based on case-control studies ...
BACKGROUND:Interventions that can facilitate early diagnosis of age-related macular degeneration (AM...
Prediction models for age-related macular degeneration (AMD) based on case-control studies have a te...
Population-based studies across developed countries have estimated the prevalence rate of late age-r...
PURPOSE: To present a computerized model assessing individualized cost utility for current treatment...
Abstract: Purpose. To study the population-based annual incidence rates of exudative, dry and all ca...
Age-related macular degeneration (AMD) is a disease that causes reduced visual acuity and blindness....